se of GentaColl after median sternotomy

Recruiting

• Conditions: J98.50; T81.8; T81.4; Other complications of procedures, not elsewhere classified; Infection following a procedure, not elsewhere classified

• Registration Number: DRKS00003244
• Lead Sponsor: Herzzentrum Dresden Universitätsklinik,Klinik für Herzchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

elecriv cardiac surgery with median sternotomy

Exclusion Criteria

urgency cardiac surgery, transplatation, endocarditis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
primary outcome: The use of GentaColl reduces the incidence of mediastinitis inbetween the 30 day follow-up after cardiac surgery with median sternotomy.<br>The classification of surgical site infections is published by Horan et al (1992), the so called CDC classification.

Secondary Outcome Measures

Name	Time	Method
hospital stay, ICU-stay, death, mild forms of surgical site infection, delir